Commonwealth Equity Services’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.2M | Sell |
172,303
-3,465
| -2% | -$125K | 0.01% | 1176 |
|
|
2025
Q1 | $6.93M | Sell |
175,768
-13,344
| -7% | -$526K | 0.01% | 1076 |
|
|
2024
Q4 | $5.69M | Sell |
189,112
-8,925
| -5% | -$269K | 0.01% | 1160 |
|
|
2024
Q3 | $4.63M | Buy |
198,037
+11,043
| +6% | +$258K | 0.01% | 1268 |
|
|
2024
Q2 | $3.33M | Buy |
186,994
+2,360
| +1% | +$42K | 0.01% | 1453 |
|
|
2024
Q1 | $2.81M | Buy |
184,634
+124
| +0.1% | +$1.89K | ﹤0.01% | 1540 |
|
|
2023
Q4 | $3.15M | Buy |
184,510
+2,110
| +1% | +$36K | 0.01% | 1395 |
|
|
2023
Q3 | $1.53M | Buy |
182,400
+29,878
| +20% | +$250K | ﹤0.01% | 1791 |
|
|
2023
Q2 | $3.79M | Sell |
152,522
-2,695
| -2% | -$67K | 0.01% | 1210 |
|
|
2023
Q1 | $2.33K | Buy |
155,217
+13,007
| +9% | +$196 | ﹤0.01% | 1470 |
|
|
2022
Q4 | $1.68M | Buy |
142,210
+22,946
| +19% | +$271K | ﹤0.01% | 1616 |
|
|
2022
Q3 | $706K | Buy |
119,264
+7,525
| +7% | +$44.5K | ﹤0.01% | 2146 |
|
|
2022
Q2 | $474K | Buy |
111,739
+97,391
| +679% | +$413K | ﹤0.01% | 2447 |
|
|
2022
Q1 | $136K | Buy |
14,348
+4,270
| +42% | +$40.5K | ﹤0.01% | 3426 |
|
|
2021
Q4 | $191K | Sell |
10,078
-1,574
| -14% | -$29.8K | ﹤0.01% | 3319 |
|
|
2021
Q3 | $387K | Buy |
11,652
+5,596
| +92% | +$186K | ﹤0.01% | 2678 |
|
|
2021
Q2 | $234K | Buy |
+6,056
| New | +$234K | ﹤0.01% | 3132 |
|